Username Password
S&P 500: 1,346.45 Change: -0.24%

ACURA PHARMACEUTICALS INC (ACUR)

Overview
Price 3.27
Price Change Today +$0.04 (+1.24%)
P&P rating Rating: 0
Zacks Rank N/A - N/A
Open Price $3.25
Previous Close $3.23
Daily Range $3.24 - $3.27
52-Week Range $2.28 - $6.80
Volume 6,262
chart
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Other Resources for ACUR
zacks.com
Commentary
Zacks Blog: Pfizer Makes Milestone Payment
July 8, 2011
Zacks Blog: FDA Approves Pfizer/Acura's Oxecta
June 23, 2011
Zacks Blog: Company News for June 21, 2011
June 21, 2011
Zacks Blog: Zacks Investment Research: Equity Market Anomalies for June 3, 2011
June 3, 2011
Zacks Blog: Fundamental Anomalies: Debt-to-Equity & Pretax Margin
June 2, 2011
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
 
No brokerage coverage for ACUR
 
ACUR Ratings:BUY  SELL  HOLD
ACUR Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

2 Buy
0 Sell
 
Free Options Trader Guide
Top Buy Analysis
BUY: ACUR Rating: 0
Company: ACURA PHARMACEUTICALS INC
Points: -101.36
Start Price: $6.95
Start Date: 05/03/2009 2:25 AM
mgbigsandco1
mgbigsandco1
P&P Score: 99.37
Recs:
No DEBT!!! and a great drug in the pipeline....bought a ton of it at 5

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 07/08/11 Pfizer Makes Milestone Payment - Analyst Blog 0
Zacks_Analysts
0.00 06/23/11 FDA Approves Pfizer/Acura's Oxecta - Analyst Blog 0
Zacks_Analysts
0.00 06/02/11 Fundamental Anomalies: Debt-to-Equity & Pretax Margin - Analyst Blog 0
Zacks_Analysts
0.00 01/24/11 Pfizer Extends King Tender Offer - Analyst Blog 0
Zacks_Analysts
0.00 12/29/10 King Pharma Resubmits Remoxy NDA - Analyst Blog 0
Zacks_Analysts
0.00 12/21/10 King Pharma Files NDA for Pain Drug - Analyst Blog 0
Zacks_Analysts
0.00 04/27/10 Zacks Analyst Blog Highlights: Sprint Nextel, Verizon, AT&T, King Pharmaceuticals, Inc. and Acura Pharmaceuticals, Inc. - Press Releases 0
Zacks_Analysts
0.00 04/26/10 FDA Panel Vote Against Acurox - Analyst Blog 0
Zacks_Analysts
0.00 04/08/10 King Advances Pain Candidate - Analyst Blog 0
Zacks_Analysts
0.00 03/18/10 Acurox to be Reviewed - Analyst Blog 0
Pages: [ 1 ]  2  >>
Commentary
BUY: ACURA PHARMACEUTICALS INC (ACUR)
Start Price: $2.69
Points: -1.79
Created: 06/11/2010
pharmacy always good

Comments: 0 | Comment

Recs:
 
BUY: ACURA PHARMACEUTICALS INC (ACUR)
Start Price: $6.95
Points: -101.36
Created: 05/03/2009
No DEBT!!! and a great drug in the pipeline....bought a ton of it at 5

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
Peterjr 99.06 BUY Three to Six Months 06/11/2010 $2.69 $3.27
(+1.55%)
+21.56% +23.35% -1.79 view
mgbigsandco1 99.37 BUY One to Three Months 05/03/2009 $6.95 $3.27
(+1.55%)
-52.95% +48.41% -101.36 view
Sponsored Links